Centaurus Financial’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,342
| Closed | -$135K | – | 858 |
|
|
2022
Q2 | $135K | Buy |
4,342
+546
| +14% | +$17K | 0.01% | 724 |
|
|
2022
Q1 | $156K | Buy |
3,796
+621
| +20% | +$25.5K | 0.01% | 737 |
|
|
2021
Q4 | $138K | Hold |
3,175
| – | – | 0.01% | 789 |
|
|
2021
Q3 | $159K | Sell |
3,175
-65
| -2% | -$3.26K | 0.01% | 717 |
|
|
2021
Q2 | $204K | Sell |
3,240
-6,130
| -65% | -$386K | 0.02% | 666 |
|
|
2021
Q1 | $871K | Buy |
+9,370
| New | +$871K | 0.09% | 259 |
|
|
2018
Q3 | – | Sell |
-2
| Closed | – | – | 914 |
|
|
2018
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 2257 |
|